Rein Therapeutics, Inc. (RNTX) Form 8-K — May 4, 2026
Rein Therapeutics, Inc. announced the closing of its underwritten public offering, issuing 50,000,000 shares of common stock at a public offering price of $1.00 per share. The company granted the underwriters a 45-day option to purchase up to an additional 7,500,000 shares to cover over-allotments. The gross proceeds from the offering totaled approximately $50 million, with net proceeds to the company estimated at $46.1 million after deducting underwriting discounts and commissions and estimated offering expenses.
Key figures
- Gross Proceeds
- $50,000,000
- Offering Price
- $1.00
- Shares Offered
- 50,000,000
- Greenshoe
- 7,500,000
- Net Proceeds
- $46.1 million
- Underwriter Warrants
- 1,725,000
- Underwriter Warrant Exercise Price
- $1.50
Price after filing
Close on the filing date to close N calendar days later (from $1.02). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.